Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bioxcel Therapeutics Inc
(NQ:
BTAI
)
0.6150
-0.0202 (-3.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bioxcel Therapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why 1847 Holdings Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 05, 2023
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) shares surged 87% to $11.78 after the company said the initial data from Phase 2 trial of Ixempra shows potential for improved clinical benefit in...
Via
Benzinga
BioXcel Therapeutics Inc. (NASDAQ: BTAI) Near the Top of Equities by Percentage Gain on 7/5
July 05, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Dow Drops 150 Points; US Factory Orders Increase 0.3% In May
July 05, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.46% to 34,259.45 while the NASDAQ fell...
Via
Benzinga
Analyst Expectations for BioXcel Therapeutics's Future
June 30, 2023
Via
Benzinga
Goldman Sachs Maintains Neutral Rating for BioXcel Therapeutics: Here's What You Need To Know
May 26, 2023
Via
Benzinga
Where BioXcel Therapeutics Stands With Analysts
May 26, 2023
Via
Benzinga
Wells Fargo To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Monday
July 03, 2023
Jefferies boosted the price target for ACM Research, Inc. (NASDAQ: ACMR) from $9 to $23.4. Jefferies analyst Nick Cheng upgraded the stock from Underperform to Buy. ACM Research shares fell 2.2% to...
Via
Benzinga
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review
June 30, 2023
Major indexes rebounded strongly and many stocks flashed buy signals.
Via
Investor's Business Daily
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of BioXcel Therapeutics, Inc. (BTAI) on Behalf of Investors
June 30, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of BioXcel Therapeutics, Inc. (BTAI) on Behalf of Investors
June 30, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against BioXcel Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
June 30, 2023
From
The Schall Law Firm
Via
Business Wire
Lost Money in BioXcel Therapeutics, Inc? Gibbs Law Group Investigates Potential Securities Law Violations
June 29, 2023
From
Gibbs Law Group
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BioXcel Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
June 29, 2023
From
The Schall Law Firm
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of BioXcel Therapeutics, Inc. (BTAI) on Behalf of Investors
June 29, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Nasdaq Moves Lower; Acuity Brands Earnings Top Estimates
June 29, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.68% to 34,081.83 while the NASDAQ fell 0.23% to 13,560.57. The S&P...
Via
Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 29, 2023
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 29, 2023
Via
Benzinga
Dow Up Triple Digits After Bank Stress Test, GDP Revision
June 29, 2023
The Dow Jones Industrial Average is up 194 points midday, while the S&P 500 Index and Nasdaq Composite move cautiously higher.
Via
Talk Markets
Crude Oil Edges Higher; McCormick Posts Upbeat Earnings
June 29, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Thursday. The Dow traded up 0.64% to 34,069.87 while the NASDAQ rose 0.13% to 13,609.09. The S&P...
Via
Benzinga
Why Shares of BioXcel Therapeutics Are Plunging Thursday
June 29, 2023
Questions regarding the safety of an Alzheimer's disease agitation therapy were raised when the company announced phase 3 trial results.
Via
The Motley Fool
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
June 29, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Are BioXcel Therapeutics Shares Plummeting Today
June 29, 2023
BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are tumbling after the company released topline results for TRANQUILITY II, a Phase 3 trial of BXCL501 for the acute treatment of
Via
Benzinga
Dow Rises Over 100 Points; US GDP Grows 2% In Q1
June 29, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.37% to 33,977.04 while the NASDAQ rose...
Via
Benzinga
FREY Stock Price Prediction: Is Freyr Battery Really Worth $13?
June 29, 2023
Freyr Battery (FREY) stock is on the move Thursday with heavy trading following positive coverage from analysts at Morgan Stanley.
Via
InvestorPlace
Why Is Cormedix (CRMD) Stock Down 23% Today?
June 29, 2023
Cormedix (CRMD) stock is falling hard on Thursday with heavy trading after the company priced a public offering of its shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 29, 2023
Via
Benzinga
Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today?
June 29, 2023
BioXcel Therapeutics (BTAI) stock is taking a beating on Thursday after the company released its latest clinical trial data.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 29, 2023
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!
Via
InvestorPlace
BioXcel CEO Vimal Mehta Says This Alzheimer's News Is A 'Huge Win For Society'
June 29, 2023
The company hopes to soon gain approval to treat patients with agitation due to Alzheimer's disease.
Via
Investor's Business Daily
3 Short-Squeeze Stocks Set for a Spectacular Gamma Squeeze Rally
June 15, 2023
If you can’t stand a dull day at the trading desk, these short-squeeze stocks to buy could spike your blood pressure and your portfolio.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.